LARGE PHARMA & MED DEVICE COMPANY: 3 YEA

LARGE PHARMA & MED DEVICE COMPANY
3 YEAR STRATEGIC PLANNING

3 Year Strategic Planning - Conducted primary research and supplemented with insights from Seagrove syndicated research to develop key strategic pillars & roadmap to differentiate the diabetes business over a 3-year period.

CHALLENGE:

The company wanted to better understand how the blood glucose monitoring market would look in 2023 and how their products will strategically fit with stakeholders’ needs. What features and level of connectivity will be needed to keep or grow share in the various vertical and horizontal customer groups? How can their products create value as stand-alone entities or in combination with alternative methods?

SOLUTION:

Conducted primary research and supplemented with insights from Seagrove syndicated research to develop key strategic pillars & roadmap to differentiate the diabetes business over a 3-year period.

PROCESS:

Conducted Research: Utilized Seagrove proprietary database to recruit clinicians, pharmacy executives & top payers to conduct a series of focus groups.

Developed Insights: Based on primary research and Seagrove syndicated data, identified critical payer and clinical insights that will drive differentiation over the 3-year strategic planning horizon.

Created Playbook: Provided detailed playbook and insights that served as the foundation for the 3-year strategic plan.